Skip to content
StockMarketAgent
Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

NSE/TARSONS stock hub

NSE/TARSONS has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

NSE/TARSONSis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
12.1B
National Stock Exchange of India
Market data

Live price

Current market quote for this ticker.

Current price
NSE/TARSONS
In the news

Latest news · NSE/TARSONS

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 24.9P50 32.4P75 45.7
Trailing P/E59.5
P25 24.8P50 35.9P75 56.9
ROEn/a
P25 6.3P50 13.6P75 18.1
ROIC1.9
P25 4.1P50 10.3P75 17.9
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All NSE/TARSONS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
174
Groups with data
10
Currency
INR
Showing 174 of 174 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
India
Country code
IN
Employees
906
Employees Change
83%
Employees Change Percent
10.09
Enterprise value
INR 15.8B
Exchange
National Stock Exchange of India
Financial currency
INR
First seen
2026-05-10
Industry
Medical Instruments & Supplies
Isin
INE144Z01023
Last refreshed
2026-05-10
Market cap
INR 12.1B
Price
INR 229
Price currency
INR
Rev Per Employee
4,572,593.82x
Sector
Healthcare
Sic
3826
Symbol
nse/TARSONS
Website
https://www.tarsons.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

10
MetricValue
Earnings Yield
1.68%
EV Earnings
77.49x
EV/EBIT
53.75x
EV/EBITDA
15.09x
EV/Sales
3.81x
P/B ratio
1.93x
P/E ratio
59.5x
P/S ratio
2.93x
PE Ratio3 Y
59.24x
PE Ratio5 Y
53.7x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

22
MetricValue
EBIT Margin
7.08%
EBITDA Margin
24.47%
Gross margin
65.13%
Gross Profit
INR 2.7B
Gross Profit Growth
6.91%
Gross Profit Growth Q
12.91%
Gross Profit Growth3 Y
7.08%
Gross Profit Growth5 Y
14.87%
Net Income
INR 203.4M
Net Income Growth
-31.92%
Net Income Growth Q
-4.24%
Net Income Growth Years
0%
Net Income Growth3 Y
-38.47%
Net Income Growth5 Y
-12.59%
Pretax Margin
7.65%
Profit Margin
4.91%
Profit Per Employee
INR 224,547
Profitable Years
7
Roa5y
11.39
Roe5y
17.17
ROIC
1.9
Roic5y
15.64

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

13
MetricValue
Cagr1y
-36.86%
Cagr3y
-25.52%
EPS Growth
-31.8
EPS Growth Q
-4.04
EPS Growth Years
0
EPS Growth3 Y
-38.46
EPS Growth5 Y
-12.55
Revenue Growth
7.48x
Revenue Growth Q
12.77x
Revenue Growth Quarters
9x
Revenue Growth Years
2x
Revenue Growth3 Y
12.79x
Revenue Growth5 Y
17.05x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

13
MetricValue
Cash
INR 312.7M
Debt
INR 4B
Debt EBITDA
INR 3.79
Debt Equity
INR 0.63
Equity
INR 6.3B
Interest Coverage
1.37
Net Cash
INR -3.6B
Net Cash By Market Cap
INR -30.09
Net Debt EBITDA
INR 3.6
Net Debt Equity
INR 0.58
Tangible Book Value
INR 5.6B
Tangible Book Value Per Share
INR 105
WACC
5.81

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

3
MetricValue
Buyback Yield
0.12%
Dividend per share
INR 0
Last Dividend
INR 2

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

36
MetricValue
1Y total return
-36.84%
200-day SMA
255.4
3Y total return
-58.69%
50-day SMA
198.2
50-day SMA vs 200-day SMA
50under200
All Time High
924.9
All Time High Change
-75.26%
All Time High Date
2021-11-29
All Time Low
164.5
All Time Low Change
39.13%
All Time Low Date
2026-03-30
ATR
10.37
Beta
0.42
Beta1y
0.5
Beta2y
0.25
Ch YTD
-1.93
High
233.5
High52
458
High52 Date
2025-05-27
High52ch
-50.04%
Low
227.1
Low52
164.5
Low52 Date
2026-03-30
Low52ch
39.13%
Ma50ch
15.44%
Price vs 200-day SMA
-10.42%
RSI
63.81
RSI Monthly
37.16
RSI Weekly
50.21
Sharpe ratio
-1.07x
Sortino ratio
-1.46
Total Return
0.12%
Tr YTD
-1.93
Tr1m
19.53%
Tr1w
2.34%
Tr3m
4.45%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
INR 293.3M
Operating Income Growth
-40.41
Operating Income Growth Q
-47.01
Operating Income Growth3 Y
-35.63
Operating Income Growth5 Y
-14.06
Operating margin
7.08

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
10,476,321%
Shares Insiders
49.21%
Shares Institutions
10.33%
Shares Out
53,206,281
Shares Qo Q
-1.06%
Shares Yo Y
-0.12%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

45
MetricValue
Average Volume
104,395.05x
Bv Per Share
117
Ch1m
19.53
Ch1w
2.34
Ch1y
-36.84
Ch3m
4.45
Ch3y
-58.86
Ch6m
-15.24
Change
0.12%
Change From Open
-1.06
Close
228.5
Days Gap
1.19
Depreciation Amortization
720,645,000
Dollar Volume
15,618,574.4
Earnings Date
2026-05-30
EBIT
INR 293.3M
EBITDA
INR 1B
EPS
INR 3.83
F Score
1
Fiscal Year End
March
Founded
1,983
Graham Number
100.35788
Graham Upside
-56.14
Income Tax
INR 113.6M
Is Primary Listing
1
Last Earnings Date
2026-02-06
Last Report Date
2025-12-31
Lynch Fair Value
INR 19.14
Lynch Upside
-91.64
Ma150
226.8
Ma150ch
0.86%
Ma20
213.4
Ma20ch
7.2%
Next Earnings Date
2026-05-30
Open
231.3
Position In Range
26.99
Price Date
2026-05-08
Price EBITDA
INR 11.95
Ptbv Ratio
2.15
Relative Volume
0.65x
Revenue
4,142,770,000x
Tax By Revenue
2.74x
Tax Rate
35.83%
Tr6m
-15.24%
Volume
68,263
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does NSE/TARSONS pay a dividend?

Capital-return profile for this ticker.

Performance

NSE/TARSONS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-36.8%
S&P 500 1Y: n/a
3Y total return
-58.7%
S&P 500 3Y: n/a
5Y total return
n/a
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns NSE/TARSONS?

Insider, institutional, and short-interest positioning.

Institutional ownership
+10.3%
Share of float held by funds and institutions
Insider ownership
+49.2%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
-0.1%
Negative means the company is buying back shares.
Technical

NSE/TARSONS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
63.8
Neutral momentum band
Price vs 200-day MA
-10.4%
50/200-day relationship not available
Beta (5Y)
0.42
Less volatile than the market
Sharpe ratio
-1.07
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About NSE/TARSONS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/TARSONS stock rating?

nse/TARSONS is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/TARSONS analysis?

The full report lives at /stocks/nse/TARSONS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/TARSONS?

The latest report frames nse/TARSONS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/TARSONS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.